Analysis | Why Lecanemab Sparks Cautious Hope in Alzheimer's Research
Briefly

It was long ago - in 1906 - that German psychiatrist Alois Alzheimer first connected a case of dementia to abnormal deposits in the brain.Modern researchers have largely proceeded on the thesis that treatments for the disease named for him would need to clear away these aberrant clumps, consisting of a protein called amyloid, that clog patients' brains.
Read at Washington Post
[
add
]
[
|
|
]